LILRB2 and neoplasm: It has been shown that in Lewis lung carcinoma- bearing LILRB2 transgenic mice, PD-L1 blockade had no effect on tumour growth, as monotherapy, whereas, LILRB2 blockade showed moderate impact, further enhanced by its combination with anti-PD-L1 [194].